Fundraising Fox
🦊/People
Sign in

Jeffrey Low

Investor

Partner, MD at Averin Capital

San Francisco

30 Under 30 2019 · Venture Capital

Find your path to Jeffrey

293 people in our graph share verified history with Jeffrey — schools, employers, funds. One of them is your warm intro.

Iva MessyunlockedJeffrey: together at Andreessen Horowitz (2018–2020)
×9Jeffrey: together at Andreessen Horowitz
Jeffrey: together at Yale School of Medicine
Jeffrey: together at CapitalG

About

Partner at Averin focused on the intersection of life sciences, healthcare, and technology, backing teams in therapeutics, care delivery, and healthcare software. Previously led life sciences and healthcare technology strategy at Novo Holdings (working with Exscientia, Tempus, Verana Health) and was a Partner at Andreessen Horowitz's inaugural Bio Fund. Holds an MD from Yale, an MBA from Harvard Business School, and an AB from Harvard.

Experience

  1. AverinPartnercurrent2025 — presentSan Francisco Bay Area
  2. Sequoia CapitalScoutcurrent2024 — presentSan Francisco Bay Area
  3. Novo HoldingsPrincipal2020 — 2025San Francisco Bay Area
  4. Andreessen HorowitzPartner, Bio Fund (now Bio + Health)2017 — 2020San Francisco Bay Area
  5. Andreessen HorowitzDeal Team Intern2016 — 2017San Francisco Bay Area
  6. CapitalGHealthcare Growth Equity Extern2016San Francisco Bay Area
  7. NovartisBiotech Venture Capital Intern, Novartis Venture Fund2015Basel Area, Switzerland
  8. dRx CapitalDigital Health Venture Capital Intern2015Basel Area, Switzerland

Colleagues at Averin Capital

Alex Lau
Partner & Chief Operating Officer at Averin Capital
Amy Therattil
Chief of Staff at Averin Capital
Ben Tomaszewski
Investor at Averin Capital
David Berry
General Partner at Flagship Pioneering
David Berry
Investor at Averin Capital
Eric Berry
Investor at Averin Capital
Oanh Sam
Director, Operations & Experience at Averin Capital
Tomer Zitelny
Partner at Averin Capital

Frequently asked questions

Who is Jeffrey Low?
Partner at Averin focused on the intersection of life sciences, healthcare, and technology, backing teams in therapeutics, care delivery, and healthcare software. Previously led life sciences and healthcare technology strategy at Novo Holdings (working with Exscientia, Tempus, Verana Health) and was a Partner at Andreessen Horowitz's inaugural Bio Fund. Holds an MD from Yale, an MBA from Harvard Business School, and an AB from Harvard.
Where does Jeffrey Low work?
Jeffrey Low is Partner, MD at Averin Capital.
Where did Jeffrey Low go to school?
Jeffrey Low studied at Harvard Business School (Master of Business Administration (MBA) | Section E); Yale School of Medicine (Doctor of Medicine (MD)); Harvard University (AB, Molecular and Cellular Biology, Secondary Field: Government | Cabot House).

Same school

Shared employers